Menu
M1 Kliniken AG decides to buy back shares
Publication of inside information pursuant to Art. 17 of Regulation (EU) No. 596/2014
Berlin, 20.04.2023 - The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,500,000 shares of the Company in a total volume not exceeding EUR 10,800,000.00 (excluding incidental acquisition costs). The resolution is based on the authorisation of the Annual General Meeting of 9 July 2020 to acquire own shares. The buyback programme is to start on 28 April 2023 and be completed by the end of 26 April 2024 at the latest. The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company. The sole purpose of the share buyback programme is to use the repurchased shares for all purposes provided for in the authorisation resolution of the Company's Annual General Meeting of 9 July 2020 and for all other purposes permitted under the law governing the Company's shares.
The buy-back programme and its implementation shall take place in compliance with the requirements of the safe harbour regulations pursuant to Art. 5 para. 2 of the Market Abuse Regulation (EU) No. 596/2014 and Art. 2, 3 and 4 of the Delegated Regulation (EU) No. 2016/1052, with the exception of the purpose of the buy-back. This is broader than determined by Art. 5 para. 2 of the Market Abuse Regulation.
Berlin, 05.05.2023 - In the period from 20.04.2023 up to and including 04.05.2023, M1 Kliniken AG has acquired 7.299 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 Acombined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
28.04.2023 |
1.895 |
7,9644 |
|
02.05.2023 |
800 |
7,96 |
|
03.05.2023 |
737 |
7,8363 |
|
04.05.2023 |
1.897 |
7,96 |
|
05.05.2023 |
1.970 |
7,56 |
|
Total |
7.299 |
|
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 12.05.2023 - In the period from 08.05.2023 up to and including 12.05.2023, M1 Kliniken AG has acquired 10.393 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
08.05.2023 |
2.042 |
7,6 |
|
09.05.2023 |
2.089 |
7,7 |
|
10.05.2023 |
2.115 |
7,64 |
|
11.05.2023 |
2.069 |
7,65 |
|
12.05.2023 |
2,078 |
7,69 |
|
Total |
10.393 |
|
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 19.05.2023 - In the period from 15.05.2023 up to and including 19.05.2023, M1 Kliniken AG has acquired 8.835 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
15.05.2023 |
2.206 |
7,8 |
|
16.05.2023 |
2.193 |
7,76 |
|
17.05.2023 |
2.267 |
7,9 |
|
18.05.2023 |
2.169 |
7,92 |
|
19.05.2023 |
- |
- |
|
Total |
8.835 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 19.05.2023 amounts to 26.527.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 26.05.2023 - In the period from 22.05.2023 up to and including 26.05.2023, M1 Kliniken AG has acquired 5.992 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
22.05.2023 |
1.131 |
7,79 |
|
23.05.2023 |
1.062 |
7,7 |
|
24.05.2023 |
1.081 |
7,54 |
|
25.05.2023 |
1.268 |
7,67 |
|
26.05.2023 |
1.450 |
7,76 |
|
Total |
5.992 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 26.05.2023 amounts to 32.519.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 02.06.2023 - In the period from 29.05.2023 up to and including 02.06.2023, M1 Kliniken AG has acquired 8.157 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
29.05.2023 |
880 |
8 |
|
30.05.2023 |
1.686 |
8,1 |
|
31.05.2023 |
1.692 |
8,01 |
|
01.06.2023 |
1.931 |
8,69 |
|
02.06.2023 |
1.968 |
8,56 |
|
Total |
8.157 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 02.06.2023 amounts to 40.676.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 09.06.2023 - In the period from 05.06.2023 up to and including 09.06.2023, M1 Kliniken AG has acquired 7.316 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
05.06.2023 |
1.975 |
8,26 |
|
06.06.2023 |
1.991 |
7,98 |
|
07.06.2023 |
1.971 |
7,9 |
|
08.06.2023 |
0 |
0 |
|
09.06.2023 |
1.379 |
7,98 |
|
Total |
7.316 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 09.06.2023 amounts to 47.992.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 16.06.2023 - In the period from 12.06.2023 up to and including 16.06.2023, M1 Kliniken AG has acquired 9.127 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
12.06.2023 |
1.779 |
7,86 |
|
13.06.2023 |
1.752 |
7,8 |
|
14.06.2023 |
1.842 |
7,76 |
|
15.06.2023 |
1.875 |
7,76 |
|
16.06.2023 |
1.879 |
7,72 |
|
Total |
9.127 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 16.06.2023 amounts to 57.119.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 23.06.2023 - In the period from 19.06.2023 up to and including 23.06.2023, M1 Kliniken AG has acquired 7.955 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
19.06.2023 |
1.970 |
7,66 |
|
20.06.2023 |
1.983 |
7,5 |
|
21.06.2023 |
2.052 |
7,5 |
|
22.06.2023 |
1.868 |
7,5 |
|
23.06.2023 |
82 |
7,56 |
|
Total |
7.955 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 23.06.2023 amounts to 65.074.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 30.06.2023 - In the period from 26.06.2023 up to and including 30.06.2023, M1 Kliniken AG has acquired 7.416 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
26.06.2023 |
1.561 |
7,68 |
|
27.06.2023 |
1.582 |
7,63 |
|
28.06.2023 |
1.568 |
7,6 |
|
29.06.2023 |
1.332 |
7,7 |
|
30.06.2023 |
1.373 |
8,22 |
|
Total |
7.416 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 30.06.2023 amounts to 72.490.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 07.07.2023 - In the period from 26.06.2023 up to and including 07.07.2023, M1 Kliniken AG has acquired 11.669 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
03.07.2023 |
2.163 |
8,00 |
|
04.07.2023 |
2.204 |
8,00 |
|
05.07.2023 |
2.408 |
7,85 |
|
06.07.2023 |
2.466 |
8,08 |
| 07.07.2023 |
2.428 |
8,22 |
|
Total |
11.669 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 07.07.2023 amounts to 84.159.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 14.07.2023 - In the period from 10.07.2023 up to and including 14.07.2023, M1 Kliniken AG has acquired 8.881 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
10.07.2023 |
2.590 |
8,02 |
|
11.07.2023 |
0 |
|
|
12.07.2023 |
2.439 |
8,11 |
|
13.07.2023 |
2.368 |
7,97 |
| 14.07.2023 |
1.484 |
7,98 |
|
Total |
8.881 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 14.07.2023 amounts to 93.040.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 21.07.2023 - In the period from 17.07.2023 up to and including 21.07.2023, M1 Kliniken AG has acquired 11.520 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
17.07.2023 |
2.342 |
8,06 |
|
18.07.2023 |
2.381 |
8,06 |
|
19.07.2023 |
2.278 |
8,09 |
|
20.07.2023 |
2.271 |
8,00 |
| 21.07.2023 |
2.248 |
8,00 |
|
Total |
11.520 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 21.07.2023 amounts to 104.560.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 28.07.2023 - In the period from 21.07.2023 up to and including 28.07.2023, M1 Kliniken AG has acquired 8.873 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
24.07.2023 |
2.205 |
7,99 |
|
25.07.2023 |
2.168 |
8,00 |
|
26.07.2023 |
2.245 |
8,02 |
|
27.07.2023 |
2.255 |
8,02 |
| 28.07.2023 |
0 |
0 |
|
Total |
8.873 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 28.07.2023 amounts to 113.433.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 04.08.2023 - In the period from 31.07.2023 up to and including 04.08.2023, M1 Kliniken AG has acquired 2.977 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
31.07.2023 |
129 |
7,90 |
|
01.08.2023 |
449 |
7,96 |
|
02.08.2023 |
976 |
7,98 |
|
03.08.2023 |
500 |
8,04 |
| 04.08.2023 |
923 |
8,08 |
|
Total |
2.977 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 04.08.2023 amounts to 116.410.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 11.08.2023 - In the period from 07.08.2023 up to and including 11.08.2023, M1 Kliniken AG has acquired 2.637 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
07.08.2023 |
899 |
8,00 |
|
08.08.2023 |
858 |
7,81 |
|
09.08.2023 |
880 |
7,78 |
|
10.08.2023 |
0 |
0 |
| 11.08.2023 |
0 |
0 |
|
Total |
2.637 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 11.08.2023 amounts to 119.047.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 18.08.2023 - In the period from 14.08.2023 up to and including 18.08.2023, M1 Kliniken AG has acquired 3.780 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
14.08.2023 |
798 |
7,78 |
|
15.08.2023 |
759 |
7,67 |
|
16.08.2023 |
774 |
7,54 |
|
17.08.2023 |
741 |
7,50 |
| 18.08.2023 |
708 |
7,52 |
|
Total |
3.780 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 18.08.2023 amounts to 122.827.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 25.08.2023 - In the period from 21.08.2023 up to and including 25.08.2023, M1 Kliniken AG has acquired 3.113 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
21.08.2023 |
695 |
7,44 |
|
22.08.2023 |
500 |
7,40 |
|
23.08.2023 |
656 |
7,38 |
|
24.08.2023 |
638 |
7,41 |
| 25.08.2023 |
624 |
7,40 |
|
Total |
3.113 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 25.08.2023 amounts to 125.940.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 01.09.2023 - In the period from 28.08.2023 up to and including 01.09.2023, M1 Kliniken AG has acquired 3.559 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
28.08.2023 |
625 |
7,44 |
|
29.08.2023 |
632 |
7,52 |
|
30.08.2023 |
649 |
7,58 |
|
31.08.2023 |
644 |
7,68 |
| 01.09.2023 |
1.009 |
8,32 |
|
Total |
3.559 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 01.09.2023 amounts to 129.499.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 08.09.2023 - In the period from 04.09.2023 up to and including 08.09.2023, M1 Kliniken AG has acquired 6.716 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
04.09.2023 |
1.242 |
8,46 |
|
05.09.2023 |
1.279 |
8,52 |
|
06.09.2023 |
1.331 |
8,64 |
|
07.09.2023 |
1.398 |
8,72 |
| 08.09.2023 |
1.466 |
8,78 |
|
Total |
6.716 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 08.09.2023 amounts to 136.215.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 15.09.2023 - In the period from 11.09.2023 up to and including 15.09.2023, M1 Kliniken AG has acquired 9.032 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
11.09.2023 |
1.626 |
9,10 |
|
12.09.2023 |
1.683 |
8,94 |
|
13.09.2023 |
1.806 |
9,06 |
|
14.09.2023 |
1.917 |
8,92 |
| 15.09.2023 |
2.000 |
9,04 |
|
Total |
9.032 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 15.09.2023 amounts to 145.247.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 22.09.2023 - In the period from 18.09.2023 up to and including 22.09.2023, M1 Kliniken AG has acquired 11.042 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
18.09.2023 |
2.080 |
9,16 |
|
19.09.2023 |
2.106 |
9,20 |
|
20.09.2023 |
2.210 |
9,28 |
|
21.09.2023 |
2.270 |
9,28 |
| 22.09.2023 |
2.376 |
9,36 |
|
Total |
11.042 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 22.09.2023 amounts to 156.289.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 29.09.2023 - In the period from 25.09.2023 up to and including 29.09.2023, M1 Kliniken AG has acquired 13.078 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
25.09.2023 |
2.499 |
9,62 |
|
26.09.2023 |
2.578 |
9,54 |
|
27.09.2023 |
2.708 |
9,50 |
|
28.09.2023 |
2.672 |
9,33 |
| 29.09.2023 |
2.621 |
9,36 |
|
Total |
13.078 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 29.09.2023 amounts to 169.367.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 06.10.2023 - In the period from 02.10.2023 up to and including 06.10.2023, M1 Kliniken AG has acquired 12.694 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
02.10.2023 |
2.484 |
9,38 |
|
03.10.2023 |
2.563 |
9,04 |
|
04.10.2023 |
2.568 |
8,90 |
|
05.10.2023 |
2.551 |
8,98 |
| 06.10.2023 |
2.528 |
8,93 |
|
Total |
12.694 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 06.10.2023 amounts to 182.061.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 13.10.2023 - In the period from 09.10.2023 up to and including 13.10.2023, M1 Kliniken AG has acquired 11.536 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
09.10.2023 |
2.410 |
8,64 |
|
10.10.2023 |
2.444 |
8,92 |
|
11.10.2023 |
2.312 |
9,00 |
|
12.10.2023 |
2.247 |
9,14 |
| 13.10.2023 |
2.123 |
8,96 |
|
Total |
11.536 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 13.10.2023 amounts to 193.597.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 20.10.2023 - In the period from 16.10.2023 up to and including 20.10.2023, M1 Kliniken AG has acquired 10.259 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
16.10.2023 |
2.133 |
8,84 |
|
17.10.2023 |
2.118 |
8,98 |
|
18.10.2023 |
2.083 |
8,84 |
|
19.10.2023 |
2.014 |
8,84 |
| 20.10.2023 |
1.911 |
8,84 |
|
Total |
10.259 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 20.10.2023 amounts to 203.856.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 27.10.2023 - In the period from 23.10.2023 up to and including 27.10.2023, M1 Kliniken AG has acquired 7.691 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
23.10.2023 |
839 |
8,54 |
|
24.10.2023 |
1.857 |
8,66 |
|
25.10.2023 |
1.771 |
8,80 |
|
26.10.2023 |
1.739 |
8,60 |
| 27.10.2023 |
1.485 |
8,84 |
|
Total |
7.691 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 27.10.2023 amounts to 211.547.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 03.11.2023 - In the period from 30.10.2023 up to and including 03.11.2023, M1 Kliniken AG has acquired 5.499 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
30.10.2023 |
1.412 |
8,60 |
|
31.10.2023 |
1.290 |
8,54 |
|
01.11.2023 |
1.364 |
8,36 |
|
02.11.2023 |
1.357 |
8,56 |
| 03.11.2023 |
76 |
8,48 |
|
Total |
5.499 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 03.11.2023 amounts to 217.046.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 10.11.2023 - In the period from 06.11.2023 up to and including 10.11.2023, M1 Kliniken AG has acquired 6.662 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
06.11.2023 |
1.449 |
8,58 |
|
07.11.2023 |
1.348 |
8,52 |
|
08.11.2023 |
1.322 |
8,48 |
|
09.11.2023 |
1.283 |
8,50 |
| 10.11.2023 |
1.260 |
8,46 |
|
Total |
6.662 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 10.11.2023 amounts to 223.708.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 17.11.2023 - In the period from 13.11.2023 up to and including 17.11.2023, M1 Kliniken AG has acquired 6.284 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
13.11.2023 |
1.276 |
8,56 |
|
14.11.2023 |
1.269 |
8,74 |
|
15.11.2023 |
1.220 |
8,98 |
|
16.11.2023 |
1.234 |
9,10 |
| 17.11.2023 |
1.285 |
9,14 |
|
Total |
6.662 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 17.11.2023 amounts to 229.992.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 24.11.2023 - In the period from 20.11.2023 up to and including 24.11.2023, M1 Kliniken AG has acquired 5.561 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
20.11.2023 |
1.164 |
9,08 |
|
21.11.2023 |
1.176 |
8,94 |
|
22.11.2023 |
1.125 |
9,03 |
|
23.11.2023 |
1.074 |
9,08 |
| 24.11.2023 |
1.022 |
9,20 |
|
Total |
5.561 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 24.11.2023 amounts to 235.553.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 01.12.2023 - In the period from 27.11.2023 up to and including 01.12.2023, M1 Kliniken AG has acquired 4.705 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
27.11.2023 |
1.032 |
9,20 |
|
28.11.2023 |
1.057 |
9,20 |
|
29.11.2023 |
910 |
9,29 |
|
30.11.2023 |
895 |
9,40 |
| 01.12.2023 |
811 |
9,36 |
|
Total |
4.705 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 01.12.2023 amounts to 240.258.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 08.12.2023 - In the period from 04.12.2023 up to and including 08.12.2023, M1 Kliniken AG has acquired 6.954 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
04.12.2023 |
891 |
9,34 |
|
05.12.2023 |
1.394 |
9,88 |
|
06.12.2023 |
1.461 |
9,83 |
|
07.12.2023 |
1.584 |
9,79 |
| 08.12.2023 |
1.624 |
9,76 |
|
Total |
6.954 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 08.12.2023 amounts to 247.212.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 15.12.2023 - In the period from 11.12.2023 up to and including 15.12.2023, M1 Kliniken AG has acquired 10.619 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
11.12.2023 |
1.902 |
10,26 |
|
12.12.2023 |
1.975 |
10,10 |
|
13.12.2023 |
2.182 |
10,22 |
|
14.12.2023 |
2.188 |
10,25 |
| 15.12.2023 |
2.372 |
10,10 |
|
Total |
10.619 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 15.12.2023 amounts to 257.831.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 22.12.2023 - In the period from 18.12.2023 up to and including 22.12.2023, M1 Kliniken AG has acquired 13.721 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
18.12.2023 |
2.483 |
10,15 |
|
19.12.2023 |
2.632 |
10,46 |
|
20.12.2023 |
2.785 |
10,33 |
|
21.12.2023 |
2.876 |
10,50 |
| 22.12.2023 |
2.945 |
10,45 |
|
Total |
13.721 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 22.12.2023 amounts to 271.552.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 29.12.2023 - In the period from 27.12.2023 up to and including 29.12.2023, M1 Kliniken AG has acquired 9.647 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
25.12.2023 |
n.a. |
n.a. |
|
26.12.2023 |
n.a. |
n.a. |
|
27.12.2023 |
3.025 |
10,91 |
|
28.12.2023 |
3.260 |
11,26 |
| 29.12.2023 |
3.362 |
11.09 |
|
Total |
9.647 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 29.12.2023 amounts to 281.199.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 05.01.2024 - In the period from 02.01.2024 up to and including 05.01.2024, M1 Kliniken AG has acquired 12.313 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
01.01.2024 |
n.a. |
n.a. |
|
02.01.2024 |
3.292 |
11,29 |
|
03.01.2024 |
3.290 |
11,10 |
|
04.01.2024 |
2.848 |
11,10 |
| 05.01.2024 |
2.883 |
10,75 |
|
Total |
12.313 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 05.01.2024 amounts to 293.512.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 12.01.2024 - In the period from 08.01.2024 up to and including 12.01.2024, M1 Kliniken AG has acquired 13.344 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
08.01.2024 |
2.798 |
10,78 |
|
09.01.2024 |
2.866 |
10,85 |
|
10.01.2024 |
2.603 |
10,99 |
|
11.01.2024 |
2.629 |
10,80 |
| 12.01.2024 |
2.448 |
10,95 |
|
Total |
13.344 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 12.01.2024 amounts to 306.856.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 19.01.2024 - In the period from 15.01.2024 up to and including 19.01.2024, M1 Kliniken AG has acquired 10.994 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
15.01.2024 |
2.483 |
10,83 |
|
16.01.2024 |
2.259 |
10,98 |
|
17.01.2024 |
2.184 |
10,80 |
|
18.01.2024 |
2.085 |
10,60 |
| 19.01.2024 |
1.983 |
10,40 |
|
Total |
10.994 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 19.01.2024 amounts to 317.850.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 26.01.2024 - In the period from 22.01.2024 up to and including 26.01.2024, M1 Kliniken AG has acquired 8.958 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
22.01.2024 |
1.943 |
10,30 |
|
23.01.2024 |
1.899 |
10,70 |
|
24.01.2024 |
1.877 |
10,55 |
|
25.01.2024 |
1.662 |
10,70 |
| 26.01.2024 |
1.577 |
10,65 |
|
Total |
8.958 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 26.01.2024 amounts to 326.808.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 02.02.2024 - In the period from 29.01.2024 up to and including 02.02.2024, M1 Kliniken AG has acquired 8.532 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
29.01.2024 |
1.490 |
11,00 |
|
30.01.2024 |
1.698 |
10,55 |
|
31.01.2024 |
1.809 |
10,70 |
|
01.02.2024 |
1.800 |
10,70 |
| 02.02.2024 |
1.735 |
10,60 |
|
Total |
8.532 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 02.02.2024 amounts to 335.340.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 09.02.2024 - In the period from 05.02.2024 up to and including 09.02.2024, M1 Kliniken AG has acquired 13.026 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
05.02.2024 |
1.941 |
10,78 |
|
06.02.2024 |
1.997 |
10,90 |
|
07.02.2024 |
2.592 |
11,55 |
|
08.02.2024 |
2.800 |
11,63 |
| 09.02.2024 |
3.696 |
12,00 |
|
Total |
13.026 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 09.02.2024 amounts to 348.366.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 16.02.2024 - In the period from 12.02.2024 up to and including 16.02.2024, M1 Kliniken AG has acquired 20.599 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
12.02.2024 |
3.757 |
11,65 |
|
13.02.2024 |
3.931 |
11,60 |
|
14.02.2024 |
4.279 |
11,34 |
|
15.02.2024 |
4.297 |
11,50 |
| 16.02.2024 |
4.335 |
11,45 |
|
Total |
20.599 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 16.02.2024 amounts to 368.965.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 23.02.2024 - In the period from 19.02.2024 up to and including 23.02.2024, M1 Kliniken AG has acquired 22.868 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
19.02.2024 |
0 |
0 |
|
20.02.2024 |
5.481 |
13,00 |
|
21.02.2024 |
5.623 |
12,86 |
|
22.02.2024 |
5.806 |
12,75 |
| 23.02.2024 |
5.958 |
12,72 |
|
Total |
22.868 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 23.02.2024 amounts to 391.833.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 01.03.2024 - In the period from 26.02.2024 up to and including 01.03.2024, M1 Kliniken AG has acquired 31.796 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
26.02.2024 |
6.116 |
13,00 |
|
27.02.2024 |
6.233 |
12,61 |
|
28.02.2024 |
6.290 |
12,92 |
|
29.02.2024 |
6.360 |
13,57 |
| 01.03.2024 |
6.797 |
13,99 |
|
Total |
31.796 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 01.03.2024 amounts to 423.629.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 08.03.2024 - In the period from 04.03.2024 up to and including 08.03.2024, M1 Kliniken AG has acquired 26.977 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
04.03.2024 |
0 |
0 |
|
05.03.2024 |
7.210 |
14,55 |
|
06.03.2024 |
6.883 |
14,73 |
|
07.03.2024 |
6.787 |
14,60 |
| 08.03.2024 |
6.097 |
14,52 |
|
Total |
26.977 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 08.03.2024 amounts to 450.606.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 15.03.2024 - In the period from 11.03.2024 up to and including 15.03.2024, M1 Kliniken AG has acquired 31.421 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
11.03.2024 |
6.048 |
14,40 |
|
12.03.2024 |
6.142 |
14,22 |
|
13.03.2024 |
6.111 |
13,57 |
|
14.03.2024 |
6.292 |
13,37 |
| 15.03.2024 |
6.828 |
12,91 |
|
Total |
31.421 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 15.03.2024 amounts to 482.027.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 22.03.2024 - In the period from 18.03.2024 up to and including 22.03.2024, M1 Kliniken AG has acquired 29.884 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
18.03.2024 |
6.147 |
13,02 |
|
19.03.2024 |
6.045 |
13,05 |
|
20.03.2024 |
5.913 |
13,05 |
|
21.03.2024 |
5.899 |
13,22 |
| 22.03.2024 |
5,880 |
13,54 |
|
Total |
29.884 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 22.03.2024 amounts to 511.911.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 28.03.2024 - In the period from 25.03.2024 up to and including 28.03.2024, M1 Kliniken AG has acquired 21.701 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
25.03.2024 |
5.809 |
13,15 |
|
26.03.2024 |
5.966 |
12,65 |
|
27.03.2024 |
6.070 |
12,82 |
|
28.03.2024 |
3.856 |
12,75 |
| 29.03.2024 |
n.a. |
n.a. |
|
Total |
21.701 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 28.03.2024 amounts to 533.612.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 05.04.2024 - In the period from 01.04.2024 up to and including 05.04.2024, M1 Kliniken AG has acquired 15.209 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
01.04.2024 |
n.a. |
n.a. |
|
02.04.2024 |
4.749 |
13,19 |
|
03.04.2024 |
2.109 |
13,58 |
|
04.04.2024 |
5.019 |
13,91 |
| 05.04.2024 |
3.332 |
13,65 |
|
Total |
15.209 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 05.04.2024 amounts to 548.821.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 12.04.2024 - In the period from 08.04.2024 up to and including 12.04.2024, M1 Kliniken AG has acquired 19.953 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
08.04.2024 |
4.788 |
13,88 |
|
09.04.2024 |
2.681 |
13,84 |
|
10.04.2024 |
4.353 |
13,93 |
|
11.04.2024 |
4.215 |
13,53 |
| 12.04.2024 |
3.916 |
13,67 |
|
Total |
19.953 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 12.04.2024 amounts to 568.774.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 19.04.2024 - In the period from 15.04.2024 up to and including 19.04.2024, M1 Kliniken AG has acquired 18.875 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
15.04.2024 |
3.875 |
13,62 |
|
16.04.2024 |
3.365 |
13,99 |
|
17.04.2024 |
3.807 |
14,25 |
|
18.04.2024 |
3.753 |
13,97 |
| 19.04.2024 |
4.075 |
13,83 |
|
Total |
18.875 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 19.04.2024 amounts to 587.649.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).
Berlin, 26.04.2024 - In the period from 22.04.2024 up to and including 26.04.2024, M1 Kliniken AG has acquired 18.711 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.
Shares were purchased as follows:
|
Date |
Number of shares |
Average price (EUR) |
|
22.04.2024 |
4.079 |
13,95 |
|
23.04.2024 |
3.719 |
13,72 |
|
24.04.2024 |
3.739 |
13,48 |
|
25.04.2024 |
3.424 |
13,18 |
| 26.04.2024 |
3.750 |
13,11 |
|
Total |
18.711 |
|
The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 26.04.2024 amounts to 606.360.
The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.
Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).